Growth Metrics

Edwards Lifesciences (EW) Restructuring Costs (2016 - 2025)

Edwards Lifesciences has reported Restructuring Costs over the past 14 years, most recently at -$103.7 million for Q4 2025.

  • Quarterly results put Restructuring Costs at -$103.7 million for Q4 2025, down 7307.14% from a year ago — trailing twelve months through Dec 2025 was -$95.2 million (down 335.64% YoY), and the annual figure for FY2025 was $13.1 million, down 67.57%.
  • Restructuring Costs for Q4 2025 was -$103.7 million at Edwards Lifesciences, down from $100000.0 in the prior quarter.
  • Over the last five years, Restructuring Costs for EW hit a ceiling of $203.5 million in Q4 2023 and a floor of -$103.7 million in Q4 2025.
  • Median Restructuring Costs over the past 5 years was $5.6 million (2022), compared with a mean of $20.6 million.
  • Biggest five-year swings in Restructuring Costs: soared 3970.0% in 2023 and later tumbled 7307.14% in 2025.
  • Edwards Lifesciences' Restructuring Costs stood at $7.1 million in 2021, then decreased by 29.58% to $5.0 million in 2022, then soared by 3970.0% to $203.5 million in 2023, then plummeted by 100.69% to -$1.4 million in 2024, then tumbled by 7307.14% to -$103.7 million in 2025.
  • The last three reported values for Restructuring Costs were -$103.7 million (Q4 2025), $100000.0 (Q3 2025), and $4.2 million (Q2 2025) per Business Quant data.